S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
PP&E Net
kr22.8m
CAGR 3-Years
-5%
CAGR 5-Years
310%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
PP&E Net
kr119.8B
CAGR 3-Years
31%
CAGR 5-Years
19%
CAGR 10-Years
18%
H Lundbeck A/S
CSE:HLUN A
PP&E Net
kr2.9B
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
PP&E Net
kr2.2B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's PP&E Net?
PP&E Net
22.8m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's PP&E Net amounts to 22.8m DKK.

What is Stenocare A/S's PP&E Net growth rate?
PP&E Net CAGR 5Y
310%

Over the last year, the PP&E Net growth was -12%. The average annual PP&E Net growth rates for Stenocare A/S have been -5% over the past three years , 310% over the past five years .

Back to Top